Preclinical models for pulmonary disease and drug delivery

Sheep lungs are in many ways similar in structure and function to human lungs – this is what makes sheep an attractive research tool for highly translational studies on pulmonary drug development and pulmonary disease.

Through our relevant expertise, and availability of disease models that parallel many features of the human condition, Allergenix offers unique access to powerful tools for preclinical validation of new drug targets and evaluation of emerging drug delivery technologies:

 Pulmonary drug administration

  • pulmonary delivery systems
  • pulmonary drug/compound delivery
  • toxicity/toxicology studies

Allergenix respiratory disease models

  • allergic asthma
  • chronic obstructive pulmonary disease
  • pulmonary fibrosis
  • other respiratory disease models


More information about our technologies and capabilities….